325 related articles for article (PubMed ID: 35011486)
1. Glycosides for Peripheral Neuropathic Pain: A Potential Medicinal Components.
Tian MM; Li YX; Liu S; Zhu CH; Lan XB; Du J; Ma L; Yang JM; Zheng P; Yu JQ; Liu N
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011486
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
3. Voltage-gated Na+ channels in neuropathic pain.
Hargus NJ; Patel MK
Expert Opin Investig Drugs; 2007 May; 16(5):635-46. PubMed ID: 17461737
[TBL] [Abstract][Full Text] [Related]
4. The GLP-1 receptor herbal agonist morroniside attenuates neuropathic pain via spinal microglial expression of IL-10 and β-endorphin.
Tang X; Wu H; Mao X; Li X; Wang Y
Biochem Biophys Res Commun; 2020 Sep; 530(3):494-499. PubMed ID: 32595037
[TBL] [Abstract][Full Text] [Related]
5. Ameliorative potential of standardized fruit extract of Pterodon pubescens Benth on neuropathic pain in mice: Evidence for the mechanisms of action.
Nucci-Martins C; Martins DF; Nascimento LF; Venzke D; Oliveira AS; Frederico MJ; Silva FR; Brighente IM; Pizzolatti MG; Santos AR
J Ethnopharmacol; 2015 Dec; 175():273-86. PubMed ID: 26386380
[TBL] [Abstract][Full Text] [Related]
6. Morroniside, a secoiridoid glycoside from Cornus officinalis, attenuates neuropathic pain by activation of spinal glucagon-like peptide-1 receptors.
Xu M; Wu HY; Liu H; Gong N; Wang YR; Wang YX
Br J Pharmacol; 2017 Apr; 174(7):580-590. PubMed ID: 28098360
[TBL] [Abstract][Full Text] [Related]
7. Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain.
Liu YY; Yin D; Chen L; Qu WM; Chen CR; Laudon M; Cheng NN; Urade Y; Huang ZL
Psychopharmacology (Berl); 2014 Oct; 231(20):3973-85. PubMed ID: 24700387
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Effects of Flavonoids on Peripheral Neuropathic Pain.
Basu P; Basu A
Molecules; 2020 Mar; 25(5):. PubMed ID: 32150953
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
Moore RA; Wiffen PJ; Derry S; Toelle T; Rice AS
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007938. PubMed ID: 24771480
[TBL] [Abstract][Full Text] [Related]
10. New Pharmacological Approaches Using Polyphenols on the Physiopathology of Neuropathic Pain.
Boadas-Vaello P; Vela JM; Verdu E
Curr Drug Targets; 2017; 18(2):160-173. PubMed ID: 27231108
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacotherapy of chronic neuropathic pain].
Otto J; Forstenpointner J; Binder A; Baron R
Internist (Berl); 2019 Jul; 60(7):711-723. PubMed ID: 31187164
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the study of pain and the Polish Neurological Society - part one.
Szczudlik A; Dobrogowski J; Wordliczek J; Stępień A; Krajnik M; Leppert W; Woroń J; Przeklasa-Muszyńska A; Kocot-Kępska M; Zajączkowska R; Janecki M; Adamczyk A; Malec-Milewska M
Neurol Neurochir Pol; 2014; 48(4):262-71. PubMed ID: 25168326
[TBL] [Abstract][Full Text] [Related]
13. Neuropathic pain in children with cancer.
Jacob E
J Pediatr Oncol Nurs; 2004; 21(6):350-7. PubMed ID: 15475472
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological management of neuropathic pain].
Bouchenaki H; Bégou M; Magy L; Hajj R; Demiot C
Therapie; 2019 Dec; 74(6):633-643. PubMed ID: 31097329
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effect of Brazilian armed spider venom toxin Tx3-3 in animal models of neuropathic pain.
Dalmolin GD; Silva CR; Rigo FK; Gomes GM; do Nascimento Cordeiro M; Richardson M; Silva MAR; Prado MAM; Gomez MV; Ferreira J
Pain; 2011 Oct; 152(10):2224-2232. PubMed ID: 21570770
[TBL] [Abstract][Full Text] [Related]
16. Challenges in the development of novel treatment strategies for neuropathic pain.
Ossipov MH; Porreca F
NeuroRx; 2005 Oct; 2(4):650-61. PubMed ID: 16489372
[TBL] [Abstract][Full Text] [Related]
17. Research progress of mechanisms and drug therapy for neuropathic pain.
Yan YY; Li CY; Zhou L; Ao LY; Fang WR; Li YM
Life Sci; 2017 Dec; 190():68-77. PubMed ID: 28964813
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
Front Immunol; 2021; 12():781310. PubMed ID: 34795678
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT-protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial.
Kerckhove N; Mallet C; Pereira B; Chenaf C; Duale C; Dubray C; Eschalier A
BMJ Open; 2016 Dec; 6(12):e013530. PubMed ID: 27986742
[TBL] [Abstract][Full Text] [Related]
20. Neuropathic low back pain in clinical practice.
Baron R; Binder A; Attal N; Casale R; Dickenson AH; Treede RD
Eur J Pain; 2016 Jul; 20(6):861-73. PubMed ID: 26935254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
